Contraceptive News and Research

RSS

Catholics for Choice supports coverage of reproductive healthcare services in healthcare policy

"Catholics believe that healthcare is a right, not a privilege. However, our vision for healthcare reform is different than the US bishops and their conservative allies, who seek to marginalize issues of reproductive health-as if people's reproductive health can be separated from their overall health. People in the United States need coverage of reproductive healthcare services, and efforts to deny this coverage based on the opinions of a small but vocal minority are unjust.

5 Sep 2009

World should contribute $23B to increase women's access to contraception, UNFPA says

The United Nations Population Fund (UNFPA) on Tuesday "appealed for the world to contribute more to improve women's health and access to contraception," Agence France-Presse reports.

4 Sep 2009

Media examine debate over UNESCO international sex education guidelines

The New York Times examines how "[a] set of proposed international sex education guidelines aimed at reducing H.I.V. infections among young people" and unplanned pregnancies, based on "more than 80 studies of sex education," has received some criticism. The release of the final guidelines, originally scheduled for next week by the United Nations Educational, Scientific and Cultural Organization (UNESCO), has been delayed.

4 Sep 2009

Catholics believe that healthcare is a right, not a privilege: Catholics for Choice

As Congress returns from the summer recess, we hope that we will soon see an honest and productive debate on truly comprehensive healthcare reform that leads to positive changes in healthcare accessibility for women and men in the United States.

4 Sep 2009

FDA approves Watson Pharmaceuticals' ANDA for Levonorgestrel tablets

Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Levonorgestrel Tablets, 0.75 mg for over-the-counter use in women ages 17 and above, as well as for prescription use in women under the age of 17.

29 Aug 2009

European Medicines Agency validates Schering-Plough's MAA for nomegestrol acetate/17 beta-estradiol

Schering-Plough Corporation, (NYSE: SGP), today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company's Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate for the maintenance treatment of asthma in patients 12 years of age and older.

27 Aug 2009

Emergency contraceptive tablet to help prevent an unintended pregnancy

There is good news for college students as they head back to campus this fall. A new emergency contraceptive, Plan B® One-Step (levonorgestrel) tablet, 1.5 mg, is now available at the local pharmacy for all students 17 and older.

24 Aug 2009

New kind of “molecular condom” to protect women from AIDS

University of Utah scientists developed a new kind of “molecular condom” to protect women from AIDS in Africa and other impoverished areas. Before sex, women would insert a vaginal gel that turns semisolid in the presence of semen, trapping AIDS virus particles in a microscopic mesh so they can’t infect vaginal cells.

10 Aug 2009

Appeals court affirms invalidation of Yasmin patent

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a ruling by the U.S. District Court for the District of New Jersey finding Bayer Schering's U.S. Patent No. 6,787,531 invalid. The patent is listed in the Orange Book for Bayer's oral contraception Yasmin®.

5 Aug 2009

University at Buffalo start-up provides innovative digital sperm analysis to infertile couples worldwide

Couples struggling with fertility problems have a new option for assessing their ability to have a child with the start-up of a new Buffalo-based company called LifeCell Dx, Inc. (LCDX).

27 Jul 2009

Researchers identify women at risk of gaining excessive weight with Depo-Provera

Researchers at the University of Texas Medical Branch at Galveston have identified women who are likely to gain weight while using depot medroxyprogesterone acetate, more commonly known as Depo-Provera or the birth control shot. These findings dispel the myth that all women who use DMPA will gain weight and will help physicians to counsel patients appropriately.

24 Jul 2009

Abortion issue could derail health reform

Nineteen Democrats have written House Speaker Nancy Pelosi promising not to vote for a health bill that includes funding for abortion, igniting a debate that has the potential to derail a health care overhaul, NPR reports.

15 Jul 2009

U.N. calls for investing in women to ensure economic recovery, reduce 'health gap'

To mark World Population Day on July 11, U.N. officials are calling for investment in women and girls during the global financial crisis as a way to promote economic recovery and tackle poverty and inequality, afrol News reports.

15 Jul 2009

Why oral contraceptives fail for obese women

Researchers have identified a potential biological mechanism that could explain why oral contraceptives may be less effective at preventing pregnancy in obese women, as some epidemiological studies have indicated.

14 Jul 2009

IRIN examines 'dramatic plunge' in family planning international donor dunding

IRIN examines how a "dramatic plunge" in international donor funding for family planning could undermine other health- and humanitarian-related goals, including fighting poverty and hunger. About 200 million women do not have access to contraception, which could cause a surge in the world's population leading to a reversal of humanitarian gains, according to some experts.

13 Jul 2009